Abstract
Angiotensin II, the primary active hormone in the Renin-Angiotensin System is a major vasoconstrictor implicated in the cause of hypertension. Research efforts have focused in the treatment of disease by blocking its release and more recently by competing its action on AT(1) receptors. This approach generated in the pharmaceutical market, losartan, and other derivatives. To better understand the stereoelectronic requirements that lead to the molecular basis of hypertension the stereochemical features of angiotensin II and its antagonists are studied.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Amino Acid Sequence
-
Angiotensin Receptor Antagonists*
-
Angiotensin-Converting Enzyme Inhibitors / chemical synthesis
-
Angiotensin-Converting Enzyme Inhibitors / chemistry
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Antihypertensive Agents / chemical synthesis*
-
Antihypertensive Agents / pharmacology
-
Antihypertensive Agents / therapeutic use*
-
Drug Design
-
Humans
-
Models, Molecular
-
Molecular Conformation
-
Protein Conformation
-
Receptor, Angiotensin, Type 1
-
Receptor, Angiotensin, Type 2
-
Receptors, Angiotensin / chemistry
-
Renin-Angiotensin System / drug effects*
-
Structure-Activity Relationship
Substances
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Antihypertensive Agents
-
Receptor, Angiotensin, Type 1
-
Receptor, Angiotensin, Type 2
-
Receptors, Angiotensin